Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Clinical trial NCT02926690 · RECRUITING

Trial details

NCT number

NCT02926690

Sponsor

OncoTherapy Science, Inc.

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-05-29

Primary completion

2027-09-01

Enrollment

70

View on ClinicalTrials.gov